• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Past, present and future of respiratory syncytial infection prevention in infants and young children.

作者信息

Esposito Susanna, Principi Nicola

机构信息

Pediatric Clinic, Pietro Barilla Children's Hospital, Department of Medicine and Surgery, University of Parma, Parma, Italy.

Università degli Studi di Milano, Milan, Italy.

出版信息

Expert Opin Pharmacother. 2025 May;26(7):783-786. doi: 10.1080/14656566.2025.2495091. Epub 2025 Apr 22.

DOI:10.1080/14656566.2025.2495091
PMID:40243138
Abstract
摘要

相似文献

1
Past, present and future of respiratory syncytial infection prevention in infants and young children.婴幼儿呼吸道合胞病毒感染预防的过去、现在与未来
Expert Opin Pharmacother. 2025 May;26(7):783-786. doi: 10.1080/14656566.2025.2495091. Epub 2025 Apr 22.
2
Respiratory Syncytial Virus Vaccine and Nirsevimab Uptake Among Pregnant People and Their Neonates.呼吸道合胞病毒疫苗及尼塞韦单抗在孕妇及其新生儿中的接种情况
JAMA Netw Open. 2025 Feb 3;8(2):e2460735. doi: 10.1001/jamanetworkopen.2024.60735.
3
Cost-effectiveness of RSVpreF vaccine and nirsevimab for the prevention of respiratory syncytial virus disease in Canadian infants.加拿大婴儿呼吸道合胞病毒疾病预防用 RSVpreF 疫苗和 nirsevimab 的成本效益分析。
Vaccine. 2024 Aug 30;42(21):126164. doi: 10.1016/j.vaccine.2024.126164. Epub 2024 Jul 30.
4
Summary of the National Advisory Committee on Immunization (NACI) Statement on the Prevention of Respiratory Syncytial Virus (RSV) in Infants.国家免疫咨询委员会（NACI）关于预防婴儿呼吸道合胞病毒（RSV）声明的摘要。
Can Commun Dis Rep. 2025 Apr 3;51(4):113-118. doi: 10.14745/ccdr.v51i04a01. eCollection 2025 Apr.
5
Cost-effectiveness analysis of nirsevimab and maternal RSVpreF vaccine strategies for prevention of Respiratory Syncytial Virus disease among infants in Canada: a simulation study.加拿大预防婴儿呼吸道合胞病毒疾病的尼塞韦单抗和母体呼吸道合胞病毒前融合蛋白疫苗策略的成本效益分析：一项模拟研究
Lancet Reg Health Am. 2023 Nov 9;28:100629. doi: 10.1016/j.lana.2023.100629. eCollection 2023 Dec.
6
Use of the Pfizer Respiratory Syncytial Virus Vaccine During Pregnancy for the Prevention of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Disease in Infants: Recommendations of the Advisory Committee on Immunization Practices - United States, 2023.《妊娠期使用辉瑞呼吸道合胞病毒疫苗预防婴儿呼吸道合胞病毒相关下呼吸道疾病：免疫实践咨询委员会建议-美国，2023 年》。
MMWR Morb Mortal Wkly Rep. 2023 Oct 13;72(41):1115-1122. doi: 10.15585/mmwr.mm7241e1.
7
Cost-effectiveness of nirsevimab and maternal RSVpreF for preventing respiratory syncytial virus disease in infants across Canada.在加拿大，尼塞韦单抗和母体呼吸道合胞病毒前融合蛋白疫苗用于预防婴儿呼吸道合胞病毒疾病的成本效益。
BMC Med. 2025 Feb 21;23(1):102. doi: 10.1186/s12916-025-03928-z.
8
Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season - New Vaccine Surveillance Network, October 2023-February 2024.2023 年 10 月至 2024 年 2 月，新疫苗监测网络对婴儿进入首个呼吸道合胞病毒季节时，尼赛珠单抗预防呼吸道合胞病毒相关住院的早期效果评估。
MMWR Morb Mortal Wkly Rep. 2024 Mar 7;73(9):209-214. doi: 10.15585/mmwr.mm7309a4.
9
Impact of routine prophylaxis with monoclonal antibodies and maternal immunisation to prevent respiratory syncytial virus hospitalisations, Lombardy region, Italy, 2024/25 season.2024/25赛季意大利伦巴第大区使用单克隆抗体进行常规预防和母体免疫对预防呼吸道合胞病毒住院的影响
Euro Surveill. 2025 Apr;30(14). doi: 10.2807/1560-7917.ES.2025.30.14.2400637.
10
Maternal Respiratory Syncytial Virus Vaccination and Receipt of Respiratory Syncytial Virus Antibody (Nirsevimab) by Infants Aged <8 Months - United States, April 2024.母亲接种呼吸道合胞病毒疫苗和 8 月龄以下婴儿接种呼吸道合胞病毒抗体（Nirsevimab）-美国，2024 年 4 月。
MMWR Morb Mortal Wkly Rep. 2024 Sep 26;73(38):837-843. doi: 10.15585/mmwr.mm7338a2.

引用本文的文献

1
Human Metapneumovirus: A Narrative Review on Emerging Strategies for Prevention and Treatment.人偏肺病毒：预防与治疗新策略的叙述性综述
Viruses. 2025 Aug 20;17(8):1140. doi: 10.3390/v17081140.
2
Predictive Factors and Clinical Markers of Recurrent Wheezing and Asthma After RSV Infection.呼吸道合胞病毒感染后反复喘息和哮喘的预测因素及临床标志物
Viruses. 2025 Jul 31;17(8):1073. doi: 10.3390/v17081073.
3
Challenges and Limitations of Current RSV Prevention Strategies in Infants and Young Children: A Narrative Review.当前婴幼儿呼吸道合胞病毒预防策略的挑战与局限：一项叙述性综述
Vaccines (Basel). 2025 Jul 1;13(7):717. doi: 10.3390/vaccines13070717.